(Q38150457)

29 August 2017

title

Impact of coffee on liver diseases: a systematic review (English)

1 reference

29 August 2017

1 reference

1

Sammy Saab

1 reference

29 August 2017

Divya Mallam

2

1 reference

29 August 2017

Gerald A Cox

series ordinal

3

1 reference

29 August 2017

Myron J Tong

series ordinal

4

1 reference

29 August 2017

publication date

15 September 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

34

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

495-504

1 reference

Coffee and health: a review of recent human research

29 August 2017

cites work

1 reference

The `Latte Revolution'? Regulation, Markets and Consumption in the Global Coffee Chain

21 January 2018

1 reference

Association of coffee consumption with gallbladder disease

21 January 2018

1 reference

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

21 January 2018

1 reference

Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies

21 January 2018

1 reference

Coffee consumption and risk of stroke in women

21 January 2018

1 reference

The relationship of coffee consumption with mortality

21 January 2018

1 reference

Association of coffee drinking with total and cause-specific mortality

21 January 2018

1 reference

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 January 2018

1 reference

Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation.

21 January 2018

1 reference

Complementary and alternative medicine in chronic liver disease

21 January 2018

1 reference

The use of complementary and alternative medicine by patients with chronic hepatitis C.

21 January 2018

1 reference

Coffee consumption and serum aminotransferases in middle-aged Japanese men.

21 January 2018

1 reference

Unexpected effects of coffee consumption on liver enzymes.

21 January 2018

1 reference

Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group.

21 January 2018

1 reference

Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee.

21 January 2018

1 reference

Erratum to "Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties".

21 January 2018

1 reference

Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial

21 January 2018

1 reference

Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index

21 January 2018

1 reference

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

Increased caffeine consumption is associated with reduced hepatic fibrosis

21 January 2018

1 reference

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States

21 January 2018

1 reference

Coffee, caffeine, and the risk of liver cirrhosis

21 January 2018

1 reference

Does coffee protect against liver cirrhosis?

21 January 2018

1 reference

The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease

21 January 2018

1 reference

Coffee, cirrhosis, and transaminase enzymes

21 January 2018

1 reference

Coffee intake and mortality from liver cirrhosis

21 January 2018

1 reference

Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.

21 January 2018

1 reference

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

21 January 2018

1 reference

Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C

21 January 2018

1 reference

Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH.

21 January 2018

1 reference

Caffeine is protective in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

21 January 2018

1 reference

Does coffee protect against hepatocellular carcinoma?

21 January 2018

1 reference

Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study

21 January 2018

1 reference

Coffee and tea consumption and risk of hepatocellular carcinoma in Italy

21 January 2018

1 reference

Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study

21 January 2018

1 reference

Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status

21 January 2018

1 reference

Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.

21 January 2018

1 reference

Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer

21 January 2018

1 reference

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

21 January 2018

1 reference

Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study

21 January 2018

1 reference

Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data

21 January 2018

1 reference

Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan

21 January 2018

1 reference

Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan

21 January 2018

1 reference

Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study

21 January 2018

1 reference

Is it time to write a prescription for coffee? Coffee and liver disease

21 January 2018

1 reference

Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways

21 January 2018

1 reference

Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach

21 January 2018

1 reference

Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.

21 January 2018

1 reference

Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway

21 January 2018

1 reference

Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells

21 January 2018

1 reference

The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat.

21 January 2018

1 reference

Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk

21 January 2018

1 reference

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

Review article: possible beneficial effects of coffee on liver disease and function

21 January 2018

1 reference

Observational research methods. Research design II: cohort, cross sectional, and case-control studies

21 January 2018

1 reference

Coffee Drinking and Serum Gamma-Glutamyltransferase

21 January 2018

1 reference

Association of caffeine intake and histological features of chronic hepatitis C

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12304

1 reference

29 August 2017

1 reference